HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Veterinary Medicine / Faculty of Veterinary Medicine >
Japanese Journal of Veterinary Research >
Volume 67 Number 1 >

Vision outcome with antiglaucoma therapy and prognostic factors in canine glaucoma: A 6-years retrospective study in Japan

Files in This Item:
p093-102 Akira Kubo.pdf2.05 MBPDFView/Open
Please use this identifier to cite or link to this item:http://doi.org/10.14943/jjvr.67.1.93

Title: Vision outcome with antiglaucoma therapy and prognostic factors in canine glaucoma: A 6-years retrospective study in Japan
Authors: Kubo, Akira Browse this author
Ito, Yosuke Browse this author
Masuko, Arisa Browse this author
Maehara, Seiya Browse this author
Miyasho, Taku Browse this author
Nakade, Tetsuya Browse this author
Keywords: Antiglaucoma therapy
canine glaucoma
prognostic factors
vision outcome
Issue Date: Feb-2019
Publisher: Faculty of Veterinary Medicine, Hokkaido University
Journal Title: Japanese Journal of Veterinary Research
Volume: 67
Issue: 1
Start Page: 93
End Page: 102
Abstract: Vision outcome provides invaluable information in clinical decision making in the management of canine glaucoma. In the present study, data of glaucoma dogs were retrospectively evaluated for vision outcome by treatment modality (with or without surgical implantation of the Ahmed glaucoma valve, AGV) and by type of glaucoma, sex and breed in cases of medically treated glaucoma. Among 1990 dogs presented with eye diseases between 2011 and 2017, 224 dogs (11.3%) were diagnosed with glaucoma at initial presentation and 228 eyes of 207 dogs have follow-up records of at least 30 days were included in the analysis. At the time of first presentation, 62/228 eyes (27.2%) were visual. Visual preservation rates were constantly significantly higher in dogs that received AGV placement with a median time to vision loss of 76.4 weeks vs. 9.6 weeks in dogs that received medical treatment alone. Among dogs treated medically, vision outcome was comparable between two types of glaucoma (i.e., primary and secondary) and between sexes. Medically treated Shiba dogs showed significantly lower vision preservation rates and a shorter median time to vision loss compared to other breeds. These results suggest that AGV implants result in better vision outcome compared to medical therapy alone and should be considered in dogs that are visual at the time of presentation and suitable for surgery. And Shiba dogs are considered as the factor that indicate poor vision outcome of medical treatment alone in the present study.
Type: bulletin (article)
URI: http://hdl.handle.net/2115/72747
Appears in Collections:Japanese Journal of Veterinary Research > Volume 67 Number 1

Submitter: 獣医学部図書室

Export metadata:


 

Feedback - Hokkaido University